Rapid jail-based implementation of overdose education and naloxone distribution in response to the COVID-19 pandemic.
COVID-19 pandemic
Implementation science
Jails
Naloxone
Practical, robust implementation and sustainability model (PRISM)
Journal
Health & justice
ISSN: 2194-7899
Titre abrégé: Health Justice
Pays: England
ID NLM: 101626355
Informations de publication
Date de publication:
27 Jun 2024
27 Jun 2024
Historique:
received:
18
10
2023
accepted:
19
06
2024
medline:
27
6
2024
pubmed:
27
6
2024
entrez:
27
6
2024
Statut:
epublish
Résumé
People incarcerated in jails are highly impacted by the opioid epidemic, and overdose education and naloxone distribution (OEND) is an effective strategy to reduce opioid overdose deaths. This study examines barriers and facilitators of fast-track OEND implementation within the jails in the Wave 1 Kentucky counties of the HEALing Communities Study during the COVID-19 pandemic. Meeting minutes with jail stakeholders were qualitatively coded using the Practical, Robust Implementation and Sustainability Model (PRISM) as the coding framework. The analysis highlighted the top barriers and facilitators to fast-track OEND implementation within the PRISM framework. Space and staffing shortages related to the COVID-19 pandemic, disruptions in interorganizational programming from pandemic-related service suspensions, and a lack of technological solutions (e.g., reliable Internet access) for socially distanced delivery were the top barriers to fast-track OEND implementation. In addition, there were limitations on non-jail staff access to jails during COVID-19. Top facilitators included jail leadership support, the option to prioritize high-risk groups, and the incorporation of OEND processes into existing communications and management software. While the COVID-19 pandemic strained jail infrastructure, jail and partner agency collaboration led to creative implementation strategies for the successful integration of OEND into jail operations. Urban jails were more likely than rural jails to be early adopters of OEND during the public health emergency. Understanding the barriers to and facilitators of OEND within jails will improve implementation efforts seeking to curb opioid overdose deaths. Jail leadership support and interorganizational efforts were key facilitators to implementation; therefore, it is recommended to increase buy-in with multiple agencies to promote success. Challenges brought on by COVID-19 have resulted in a need for innovative solutions for implementation. ClinicalTrials.gov, NCT04111939, Submitted 30 September 2019, https://clinicaltrials.gov/study/NCT04111939?titles=HEALing%20Communities%20Study&rank=1 .
Sections du résumé
BACKGROUND
BACKGROUND
People incarcerated in jails are highly impacted by the opioid epidemic, and overdose education and naloxone distribution (OEND) is an effective strategy to reduce opioid overdose deaths. This study examines barriers and facilitators of fast-track OEND implementation within the jails in the Wave 1 Kentucky counties of the HEALing Communities Study during the COVID-19 pandemic.
METHODS
METHODS
Meeting minutes with jail stakeholders were qualitatively coded using the Practical, Robust Implementation and Sustainability Model (PRISM) as the coding framework. The analysis highlighted the top barriers and facilitators to fast-track OEND implementation within the PRISM framework.
RESULTS
RESULTS
Space and staffing shortages related to the COVID-19 pandemic, disruptions in interorganizational programming from pandemic-related service suspensions, and a lack of technological solutions (e.g., reliable Internet access) for socially distanced delivery were the top barriers to fast-track OEND implementation. In addition, there were limitations on non-jail staff access to jails during COVID-19. Top facilitators included jail leadership support, the option to prioritize high-risk groups, and the incorporation of OEND processes into existing communications and management software. While the COVID-19 pandemic strained jail infrastructure, jail and partner agency collaboration led to creative implementation strategies for the successful integration of OEND into jail operations. Urban jails were more likely than rural jails to be early adopters of OEND during the public health emergency.
CONCLUSIONS
CONCLUSIONS
Understanding the barriers to and facilitators of OEND within jails will improve implementation efforts seeking to curb opioid overdose deaths. Jail leadership support and interorganizational efforts were key facilitators to implementation; therefore, it is recommended to increase buy-in with multiple agencies to promote success. Challenges brought on by COVID-19 have resulted in a need for innovative solutions for implementation.
CLINICAL TRIAL INFORMATION
BACKGROUND
ClinicalTrials.gov, NCT04111939, Submitted 30 September 2019, https://clinicaltrials.gov/study/NCT04111939?titles=HEALing%20Communities%20Study&rank=1 .
Identifiants
pubmed: 38935213
doi: 10.1186/s40352-024-00283-8
pii: 10.1186/s40352-024-00283-8
doi:
Banques de données
ClinicalTrials.gov
['NCT04111939']
Types de publication
Journal Article
Langues
eng
Pagination
27Subventions
Organisme : NIDA NIH HHS
ID : UM1DA049406
Pays : United States
Informations de copyright
© 2024. The Author(s).
Références
Aarons, G. A., Ehrhart, M. G., Farahnak, L. R., & Sklar, M. (2014). Aligning leadership across systems and organizations to develop a strategic climate for evidence-based practice implementation. Annual Review of Public Health, 35(1), 255–274. https://doi.org/10.1146/annurev-publhealth-032013-182447
doi: 10.1146/annurev-publhealth-032013-182447
Aarons, G. A., Green, A. E., Trott, E., Willging, C. E., Torres, E. M., Ehrhart, M. G., & Roesch, S. C. (2016). The roles of system and organizational leadership in system-wide evidence-based intervention sustainment: A mixed-method study. Administration and Policy in Mental Health and Mental Health Services Research, 43(6), 991–1008. https://doi.org/10.1007/s10488-016-0751-4
doi: 10.1007/s10488-016-0751-4
Akiyama, M. J., Spaulding, A. C., & Rich, J. D. (2020). Flattening the curve for incarcerated populations—Covid-19 in jails and prisons. New England Journal of Medicine, 382(22), 2075–2077. https://doi.org/10.1056/NEJMp2005687
doi: 10.1056/NEJMp2005687
Anthony-North, V., Pope, L. G., Pottinger, S., & Sederbaum, I. (2018). Corrections-based responses to the opioid epidemic: Lessons from New York State’s overdose education and naloxone distribution program. Vera Institute of Justice. https://www.vera.org/publications/corrections-responses-to-opioid-epidemic-new-york-state
Barocas, J. A., Baker, L., Hull, S. J., Stokes, S., & Westergaard, R. P. (2015). High uptake of naloxone-based overdose prevention training among previously incarcerated syringe-exchange program participants. Drug and Alcohol Dependence, 154, 283–286. https://doi.org/10.1016/j.drugalcdep.2015.06.023
doi: 10.1016/j.drugalcdep.2015.06.023
Binswanger, I. A., Stern, M. F., Deyo, R. A., Heagerty, P. J., Cheadle, A., Elmore, J. G., & Koepsell, T. D. (2007). Release from prison—A high risk of death for former inmates. New England Journal of Medicine, 356(2), 157–165. https://doi.org/10.1056/NEJMsa064115
doi: 10.1056/NEJMsa064115
Binswanger, I. A., Blatchford, P. J., Mueller, S. R., & Stern, M. F. (2013). Mortality after prison release: Opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009. Annals of Internal Medicine, 159(9), 592–600.
doi: 10.7326/0003-4819-159-9-201311050-00005
Centers for Disease Control and Prevention (2022, May 3). Guidance on prevention and management of Coronavirus disease 2019 (COVID-19) in correctional and detention facilities. https://www.cdc.gov/coronavirus/2019-ncov/community/correction-detention/guidance-correctional-detention.html
Centers for Disease Control and Prevention (2020, December 17). Increase in fatal drug overdoses across the United States driven by synthetic opioids before and during the COVID-19 pandemic. Health Alert Network (HAN). https://emergency.cdc.gov/han/2020/han00438.asp
Chandler, R. K., Villani, J., Clarke, T., McCance-Katz, E. F., & Volkow, N. D. (2020). Addressing opioid overdose deaths: The vision for the HEALing communities Study. Drug and Alcohol Dependence, 217, 108329. https://doi.org/10.1016/j.drugalcdep.2020.108329
doi: 10.1016/j.drugalcdep.2020.108329
Collins, A. B., Ndoye, C. D., Arene-Morley, D., & Marshall, B. D. L. (2020). Addressing co-occurring public health emergencies: The importance of naloxone distribution in the era of COVID-19. International Journal of Drug Policy, 83, 102872. https://doi.org/10.1016/j.drugpo.2020.102872
doi: 10.1016/j.drugpo.2020.102872
Curtis, M., Dietze, P., Aitken, C., Kirwan, A., Kinner, S. A., Butler, T., & Stoové, M. (2018). Acceptability of prison-based take-home naloxone programmes among a cohort of incarcerated men with a history of regular injecting drug use. Harm Reduction Journal, 15(1), 48. https://doi.org/10.1186/s12954-018-0255-5
doi: 10.1186/s12954-018-0255-5
Davidson, P. J., Wagner, K. D., Tokar, P. L., & Scholar, S. (2019). Documenting need for naloxone distribution in the Los Angeles County jail system. Addictive Behaviors, 92, 20–23. https://doi.org/10.1016/j.addbeh.2018.12.017
doi: 10.1016/j.addbeh.2018.12.017
Degenhardt, L., Grebely, J., Stone, J., Hickman, M., Vickerman, P., Marshall, B. D. L., Bruneau, J., Altice, F. L., Henderson, G., Rahimi-Movaghar, A., & Larney, S. (2019). Global patterns of opioid use and dependence: Harms to populations, interventions, and future action. The Lancet, 394(10208), 1560–1579. https://doi.org/10.1016/S0140-6736(19)32229-9
doi: 10.1016/S0140-6736(19)32229-9
Donelan, C. J., Hayes, E., Potee, R. A., Schwartz, L., & Evans, E. A. (2021). COVID-19 and treating incarcerated populations for opioid use disorder. Journal of Substance Abuse Treatment, 124, 108216. https://doi.org/10.1016/j.jsat.2020.108216
doi: 10.1016/j.jsat.2020.108216
Drabinski, E., & Rabina, D. (2015). Reference services to incarcerated people, part I: Themes emerging from answering reference questions from prisons and jails. Reference and User Services Quarterly, 55(1), 42–48.
doi: 10.5860/rusq.55n1.42
El-Bassel, N., Jackson, R. D., Samet, J., & Walsh, S. L. (2020). Introduction to the special issue on the HEALing communities Study. Drug and Alcohol Dependence, 217, 108327. https://doi.org/10.1016/j.drugalcdep.2020.108327
doi: 10.1016/j.drugalcdep.2020.108327
Fagan, A. A., Bumbarger, B. K., Barth, R. P., Bradshaw, C. P., Cooper, B. R., Supplee, L. H., & Walker, D. K. (2019). Scaling up evidence-based interventions in US public systems to prevent behavioral health problems: Challenges and opportunities. Prevention Science, 20(8), 1147–1168. https://doi.org/10.1007/s11121-019-01048-8
doi: 10.1007/s11121-019-01048-8
Farrell, M., & Marsden, J. (2008). Acute risk of drug-related death among newly released prisoners in England and Wales. Addiction, 103(2), 251–255. https://doi.org/10.1111/j.1360-0443.2007.02081.x
doi: 10.1111/j.1360-0443.2007.02081.x
Faust, J. S., Du, C., Mayes, K. D., Li, S. X., Lin, Z., Barnett, M. L., & Krumholz, H. M. (2021). Mortality from drug overdoses, homicides, unintentional injuries, motor vehicle crashes, and suicides during the pandemic, March-August 2020. Jama, 326(1), 84–86. https://doi.org/10.1001/jama.2021.8414
doi: 10.1001/jama.2021.8414
Fazel, S., Yoon, I. A., & Hayes, A. J. (2017). Substance use disorders in prisoners: An updated systematic review and meta-regression analysis in recently incarcerated men and women. Addiction, 112(10), 1725–1739. https://doi.org/10.1111/add.13877
doi: 10.1111/add.13877
Feldstein, A. C., & Glasgow, R. E. (2008). A practical, robust implementation and sustainability model (PRISM) for integrating research findings into practice. The Joint Commission Journal on Quality and Patient Safety, 34(4), 228–243. https://doi.org/10.1016/S1553-7250(08)34030-6
doi: 10.1016/S1553-7250(08)34030-6
Friedman, J., & Akre, S. (2021). COVID-19 and the drug overdose crisis: Uncovering the deadliest months in the United States, January–July 2020. American Journal of Public Health, 111(7), 1284–1291. https://doi.org/10.2105/AJPH.2021.306256
doi: 10.2105/AJPH.2021.306256
Giglio, R. E., Li, G., & DiMaggio, C. J. (2015). Effectiveness of bystander naloxone administration and overdose education programs: A meta-analysis. Injury Epidemiology, 2(1), 10. https://doi.org/10.1186/s40621-015-0041-8
doi: 10.1186/s40621-015-0041-8
Grella, C. E., Ostlie, E., Scott, C. K., Dennis, M. L., Carnevale, J., & Watson, D. P. (2021). A scoping review of factors that influence opioid overdose prevention for justice-involved populations. Substance Abuse Treatment Prevention and Policy, 16(1), 19. https://doi.org/10.1186/s13011-021-00346-1
doi: 10.1186/s13011-021-00346-1
Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009). Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support. Journal of Biomedical Informatics, 42(2), 377–381. https://doi.org/10.1016/j.jbi.2008.08.010
doi: 10.1016/j.jbi.2008.08.010
Hedegaard, H., Miniño, A., Spencer, M., & Warner, M. (2021). Drug overdose deaths in the United States, 1999–2020 (Data Brief No. 428). National Center for Health Statistics. https://stacks.cdc.gov/view/cdc/112340
Horton, M., McDonald, R., Green, T. C., Nielsen, S., Strang, J., Degenhardt, L., & Larney, S. (2017). A mapping review of take-home naloxone for people released from correctional settings. International Journal of Drug Policy, 46, 7–16. https://doi.org/10.1016/j.drugpo.2017.05.015
doi: 10.1016/j.drugpo.2017.05.015
Hsieh, H. F., & Shannon, S. E. (2005). Three approaches to qualitative content analysis. Qualitative Health Research, 15(9), 1277–1288. https://doi.org/10.1177/1049732305276687
doi: 10.1177/1049732305276687
Huhn, A. S., Strain, E. C., Jardot, J., Turner, G., Bergeria, C. L., Nayak, S., & Dunn, K. E. (2022). Treatment disruption and childcare responsibility as risk factors for drug and alcohol use in persons in treatment for substance use disorders during the COVID-19 crisis. Journal of Addiction Medicine, 16(1), e8. https://doi.org/10.1097/ADM.0000000000000813
doi: 10.1097/ADM.0000000000000813
Institution for Health Metrics and Evaluation (IHME) (2021). Global Health Data Exchange. Institution for Health Metrics and Evaluation (IHME). http://ghdx.healthdata.org/gbd-results-tool?params=gbd-api-2019-permalink/c0b6f59535bbc77251e1aac20c7241ab
Kim, H., Hughes, E., Cavanagh, A., Norris, E., Gao, A., Bondy, S. J., McLeod, K. E., Kanagalingam, T., & Kouyoumdjian, F. G. (2022). The health impacts of the COVID-19 pandemic on adults who experience imprisonment globally: A mixed methods systematic review. PLOS ONE, 17(5), e0268866. https://doi.org/10.1371/journal.pone.0268866
doi: 10.1371/journal.pone.0268866
Knudsen, H. K., Drainoni, M. L., Gilbert, L., Huerta, T. R., Oser, C. B., Aldrich, A. M., Campbell, A. N. C., Crable, E. L., Garner, B. R., Glasgow, L. M., Goddard-Eckrich, D., Marks, K. R., McAlearney, A. S., Oga, E. A., Scalise, A. L., & Walker, D. M. (2020). Model and approach for assessing implementation context and fidelity in the HEALing communities Study. Drug and Alcohol Dependence, 217, 108330. https://doi.org/10.1016/j.drugalcdep.2020.108330
doi: 10.1016/j.drugalcdep.2020.108330
Knudsen, H. K., Freeman, P., Oyler, D., Oser, C. B., & Walsh, S. L. (2023). Scaling up overdose education and naloxone distribution in Kentucky: A hub with many spokes model. Addiction Science & Clinical Practice, 18, 72. https://doi.org/10.1186/s13772-023-00426-6
doi: 10.1186/s13722-023-00426-6
Krausz, R. M., Westenberg, J. N., & Ziafat, K. (2021). The opioid overdose crisis as a global health challenge. Current Opinion in Psychiatry, 34(4), 405. https://doi.org/10.1097/YCO.0000000000000712
doi: 10.1097/YCO.0000000000000712
Krawczyk, N., Picher, C. E., Feder, K. A., & Saloner, B. (2017). Only one in twenty justice-referred adults in specialty treatment for opioid use receive methadone or buprenorphine. Health Affairs, 36(12), 2046–2053. https://doi.org/10.1377/hlthaff.2017.0890
doi: 10.1377/hlthaff.2017.0890
Krinsky, C. S., Lathrop, S. L., Brown, P., & Nolte, K. B. (2009). Drugs, detention, and death: A study of the mortality of recently released prisoners. The American Journal of Forensic Medicine and Pathology, 30(1), 6–9. https://doi.org/10.1097/PAF.0b013e3181873784
doi: 10.1097/PAF.0b013e3181873784
Leip, L. A., & Stinchcomb, J. B. (2013). Should I stay or should I go? Job satisfaction and turnover intent of jail staff throughout the United States. Criminal Justice Review, 38(2), 226–241. https://doi.org/10.1177/0734016813478822
doi: 10.1177/0734016813478822
LeMasters, K., Brinkley-Rubinstein, L., Maner, M., Peterson, M., Nowotny, K., & Bailey, Z. (2022). Carceral epidemiology: Mass incarceration and structural racism during the COVID-19 pandemic. The Lancet Public Health, 7(3), e287–e290. https://doi.org/10.1016/S2468-2667(22)00005-6
doi: 10.1016/S2468-2667(22)00005-6
Lim, S., Seligson, A. L., Parvez, F. M., Luther, C. W., Mavinkurve, M. P., Binswanger, I. A., & Kerker, B. D. (2012). Risks of drug-related death, suicide, and homicide during the immediate post-release period among people released from New York City jails, 2001–2005. American Journal of Epidemiology, 175(6), 519–526. https://doi.org/10.1093/aje/kwr327
doi: 10.1093/aje/kwr327
Mark, T. L., Gibbons, B., Barnosky, A., Padwa, H., & Joshi, V. (2021). Changes in admissions to specialty addiction treatment facilities in California during the COVID-19 pandemic. JAMA Network Open, 4(7), e2117029. https://doi.org/10.1001/jamanetworkopen.2021.17029
doi: 10.1001/jamanetworkopen.2021.17029
Maruschak, L. M., Berzofsky, M., & Unangst, J. (2015). Medical problems of state and federal prisoners and jail inmates, 2011-12 (Special Report NCJ 248491). US Department of Justice, Office of Justice Programs, Bureau of Justice. https://www.bjs.gov/content/pub/pdf/mpsfpji1112.pdf
McDonald, R., Campbell, N. D., & Strang, J. (2017). Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids—conception and maturation. Drug and Alcohol Dependence, 178, 176–187. https://doi.org/10.1016/j.drugalcdep.2017.05.001
doi: 10.1016/j.drugalcdep.2017.05.001
Merrall, E. L., Kariminia, A., Binswanger, I. A., Hobbs, M. S., Farrell, M., Marsden, J., Hutchinson, S. J., & Bird, S. M. (2010). Meta-analysis of drug-related deaths soon after release from prison. Addiction, 105(9), 1545–1554. https://doi.org/10.1111/j.1360-0443.2010.02990.x
doi: 10.1111/j.1360-0443.2010.02990.x
Novisky, M. A., Nowotny, K. M., Jackson, D. B., Testa, A., & Vaughn, M. G. (2021). Incarceration as a fundamental social cause of health inequalities: Jails, prisons and vulnerability to COVID-19. The British Journal of Criminology, azab023. https://doi.org/10.1093/bjc/azab023
Nowotny, K., Bailey, Z., Omori, M., & Brinkley-Rubinstein, L. (2020). COVID-19 exposes need for progressive criminal justice reform. American Journal of Public Health, 110(7), 967–968. https://doi.org/10.2105/AJPH.2020.305707
doi: 10.2105/AJPH.2020.305707
Prescription Drug Abuse Policy System (PDAPS) (2022, January 1). Naloxone overdose prevention laws. https://pdaps.org/datasets/laws-regulating-administration-of-naloxone-1501695139
Ranapurwala, S. I., Shanahan, M. E., Alexandridis, A. A., Proescholdbell, S. K., Naumann, R. B., Edwards Jr, D., & Marshall, S. W. (2018). Opioid overdose mortality among former North Carolina inmates: 2000–2015. American Journal of Public Health, 108(9), 1207–1213. https://doi.org/10.2105/AJPH.2018.304514
doi: 10.2105/AJPH.2018.304514
Rogers, E. M. (2003). Diffusion of innovations (5th ed.). Free.
Sander, G., Shirley-Beavan, S., & Stone, K. (2019). The global state of harm reduction in prisons. Journal of Correctional Health Care, 25(2), 105–120. https://doi.org/10.1177/1078345819837909
doi: 10.1177/1078345819837909
Slavova, S., Quesinberry, D., Hargrove, S., Rock, P., Brancato, C., Freeman, P. R., & Walsh, S. L. (2021). Trends in drug overdose mortality rates in Kentucky, 2019–2020. JAMA Network Open, 4(7), e2116391–e2116391. https://doi.org/10.1001/jamanetworkopen.2021.16391
doi: 10.1001/jamanetworkopen.2021.16391
Smart, R., Pardo, B., & Davis, C. S. (2021). Systematic review of the emerging literature on the effectiveness of naloxone access laws in the United States. Addiction (Abingdon England), 116(1), 6–17. https://doi.org/10.1111/add.15163
doi: 10.1111/add.15163
Sprague Martinez, L., Rapkin, B. D., Young, A., Freisthler, B., Glasgow, L., Hunt, T., Salsberry, P. J., Oga, E. A., Bennet-Fallin, A., Plouck, T. J., Drainoni, M. L., Freeman, P. R., Surratt, H., Gulley, J., Hamilton, G. A., Bowman, P., Roeber, C. A., El-Bassel, N., & Battaglia, T. (2020). Community engagement to implement evidence-based practices in the HEALing communities study. Drug and Alcohol Dependence, 217, 108326. https://doi.org/10.1016/j.drugalcdep.2020.108326
doi: 10.1016/j.drugalcdep.2020.108326
Stone, K., & Shirley-Beavan, S. (2018). The global state of harm reduction 2018 [Report]. Harm Reduction International. https://apo.org.au/node/210261
Tanz, L. J., Dinwiddie, A. T., Snodgrass, S., O’Donnell, J., Mattson, C. L., & Davis, N. L. (2022). Drug overdose deaths in 28 states and the District of Columbia: 2020 data from the State Unintentional Drug Overdose Reporting System. Centers for Disease Control and Prevention. SUDORS Data Brief No. 2 https://stacks.cdc.gov/view/cdc/120987
Townsend, T., Blostein, F., Doan, T., Madson-Olson, S., Galecki, P., & Hutton, D. W. (2020). Cost-effectiveness analysis of alternative naloxone distribution strategies: First responder and lay distribution in the United States. International Journal of Drug Policy, 75, 102536. https://doi.org/10.1016/j.drugpo.2019.07.031
doi: 10.1016/j.drugpo.2019.07.031
Turney, K., & Conner, E. (2019). Jail incarceration: A common and consequential form of criminal justice contact. Annual Review of Criminology, 2(1), 265–290. https://doi.org/10.1146/annurev-criminol-011518-024601
doi: 10.1146/annurev-criminol-011518-024601
U.S. Food & Drug Administration. (2023, March 30). FDA approves first over-the-counter naloxone nasal spray. [ https://www.fda.gov/news-events/press-announcements/fda-approves-first-over-counter-naloxone-nasal-spray ].
United States Department of Agriculture (USDA) Economic Research Service (ERS) (2020, December 10). Rural-urban continuum codes. https://www.ers.usda.gov/data-products/rural-urban-continuum-codes.aspx
United Nations News (2021, March 9). Impact of COVID-19 ‘heavily felt’ by prisoners globally: UN expert | UN News. United Nations News. https://news.un.org/en/story/2021/03/1086802
Vera (2022, March 24). Incarceration trends: Kentucky. https://trends.vera.org/state/KY
Wallace, M., Hagan, L., Curran, K., Williams, S., Handanagic, S., & Marlow, M. (2020). COVID-19 in correctional and detention facilities—United States, February–April 2020. MMWR Morbidity and Mortality Weekly Report, 69. https://doi.org/10.15585/mmwr.mm6919e1
Walsh, S. L., El-Bassel, N., Jackson, R. D., Samet, J. H., Aggarwal, M., Aldridge, A. P., Baker, T., Barbosa, C., Barocas, J. A., Battaglia, T. A., Beers, D., Bernson, D., Bowers-Sword, R., Bridden, C., Brown, J. L., Bush, H. M., Bush, J. L., Button, A., Campbell, A. N. C., & Chandler, R. K. (2020). The HEALing (helping to End Addiction Long-Term SM) communities Study: Protocol for a cluster randomized trial at the community level to reduce opioid overdose deaths through implementation of an integrated set of evidence-based practices. Drug and Alcohol Dependence, 217, 108335. https://doi.org/10.1016/j.drugalcdep.2020.108335
doi: 10.1016/j.drugalcdep.2020.108335
Waly, G. F., Ghebreyesus, T. A., Byanyima, W., & Bachelet, M. (2020, May 13). UNODC, WHO, UNAIDS and OHCHR joint statement on COVID-19 in prisons and other closed settings. World Health Organization. https://www.who.int/news/item/13-05-2020-unodc-who-unaids-and-ohchr-joint-statement-on-covid-19-in-prisons-and-other-closed-settings
Weiner, B. J., Amick, H., & Lee, S. Y. D. (2008). Conceptualization and measurement of organizational readiness for change: A review of the literature in health services research and other fields. Medical Care Research and Review, 65(4), 379–436. https://doi.org/10.1177/1077558708317802
doi: 10.1177/1077558708317802
Wenger, L. D., Showalter, D., Lambdin, B., Leiva, D., Wheeler, E., Davidson, P. J., Coffin, P. O., Binswanger, I. A., & Kral, A. H. (2019). Overdose education and naloxone distribution in the San Francisco County jail. Journal of Correctional Health Care, 25(4), 394–404. https://doi.org/10.1177/1078345819882771
doi: 10.1177/1078345819882771
Williams, N. J., Wolk, C. B., Becker-Haimes, E. M., & Beidas, R. S. (2020). Testing a theory of strategic implementation leadership, implementation climate, and clinicians’ use of evidence-based practice: A 5-year panel analysis. Implementation Science, 15(1), 10. https://doi.org/10.1186/s13012-020-0970-7
doi: 10.1186/s13012-020-0970-7
Winhusen, T., Walley, A., Fanucchi, L. C., Hunt, T., Lyons, M., Lofwall, M., Brown, J. L., Freeman, P. R., Nunes, E., Beers, D., Saitz, R., Stambaugh, L., Oga, E. A., Herron, N., Baker, T., Cook, C. D., Roberts, M. F., Alford, D. P., Starrels, J. L., & Chandler, R. K. (2020). The opioid-overdose reduction continuum of Care Approach (ORCCA): Evidence-based practices in the HEALing communities Study. Drug and Alcohol Dependence, 217, 108325. https://doi.org/10.1016/j.drugalcdep.2020.108325
doi: 10.1016/j.drugalcdep.2020.108325
Winter, R. J., Young, J. T., Stoové, M., Agius, P. A., Hellard, M. E., & Kinner, S. A. (2016). Resumption of injecting drug use following release from prison in Australia. Drug and Alcohol Dependence, 168, 104–111. https://doi.org/10.1016/j.drugalcdep.2016.08.640
doi: 10.1016/j.drugalcdep.2016.08.640
Young, A. M., Brown, J. L., Hunt, T., Martinez, L. S. S., Chandler, R., Oga, E., Winhusen, T. J., Baker, T., Battaglia, T., Bowers-Sword, R., Button, A., Fallin-Bennett, A., Fanucchi, L., Freeman, P., Glasgow, L. M., Gulley, J., Kendell, C., Lofwall, M., Lyons, M. S., & Walsh, S. L. (2022). Protocol for community-driven selection of strategies to implement evidence-based practices to reduce opioid overdoses in the HEALing communities Study: A trial to evaluate a community-engaged intervention in Kentucky, Massachusetts, New York and Ohio. British Medical Journal Open, 12(9), e059328. https://doi.org/10.1136/bmjopen-2021-059328
doi: 10.1136/bmjopen-2021-059328